Press Releases
-
KKR-backed Biosynth Carbosynth Acquires vivitide and Welcomes Ampersand Capital Partners as New Shareholder
Combination of Biosynth Carbosynth and vivitide creates global life sciences platform serving high-growth biopharma and diagnostics end markets London, 17 March 2022 - KKR, a leading global investment firm, announced today the closing of its...
Mar 17, 2022 -
INDUSTRY ERA RECOGNIZES CEO & PRESIDENT MARTINA DIEKMANN FOR HER LEADERSHIP
May 4, 2021Industry Era Magazine “A True Mentor & Leader” Dr. Martina Diekmann, CEO of vivitide, has been a beacon of positive attitude from the pandemic's very onset. A leadership characteristic of hers is that...
May 06, 2021 -
Announcing vivitide, a New Name in the World of Peptides and Antibodies
Press Release - January 15, 2021 GARDNER, Mass. - January 15, 2021 - Delighted to announce the new company name, vivitide unites the vision and capabilities of previously merged New England Peptide and Peptides International under one,...
Jan 15, 2021 -
New England Peptide Receives Massachusetts Manufacturer of the Year Award
5th Annual Massachusetts Manufacturer of the Year Press Release - updated: Oct 28, 2020 16:19 EDT GARDNER, Mass., October 28, 2020 (Newswire.com) - New England Peptide announced today that the company has been named...
Oct 28, 2020 -
New England Peptide Announces Dr. Martina Diekmann as CEO and David Gavlik as CFO
Gardner, MA, and Louisville, KY, March 5th, 2020 New England Peptide, a leading provider of peptides for pharmaceutical research and development, which recently acquired Peptides International, today announced the appointment of Martina Diekmann, Ph.D., to...
Mar 05, 2020 -
New England Peptide and Peptides International Have Merged
December 12, 2019 Dear Valued Customer,We are excited to announce the merger of New England Peptide and Peptides International. This partnership will vastly expand the products and services that our customers have come to expect...
Dec 12, 2019 -
New England Peptide Receives Growth Equity Investment From Ampersand Capital Partners
News provided by Ampersand Capital Partners GARDNER, Mass., Oct. 8, 2019 /PRNewswire/ -- New England Peptide, a leading provider of high-quality custom peptides and antibodies to the global life sciences market, today announced the majority...
Oct 08, 2019